FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Arnoldo Barbosa

Research Profile

Chemicals & Drugs

Disorders

Falciparum Malaria

Living Beings

Co-author Network

Publications

TOP 3
Tamara K Berthoud; Ruth Aguilar; Pedro L Alonso; Arnoldo Barbosa; Caterina Guinovart; Maria Nelia Manaca; Laura Puyol; Diana Quelhas; Carlota Dobaño
Comparison of commercial kits to measure cytokine responses to Plasmodium falciparum by multiplex microsphere suspension array technology.
John J Aponte; Pedro Aide; Montse Renom; Inacio Mandomando; Quique Bassat; Jahit Sacarlal; M Nelia Manaca; Sarah Lafuente; Arnoldo Barbosa; Amanda Leach; Marc Lievens; Johan Vekemans; Betuel Sigauque; Marie-Claude Dubois; Marie-Ange Demoitié; Marla Sillman; Barbara Savarese; John G McNeil; Eusebio Macete; W Ripley Ballou; Joe Cohen; Pedro L Alonso
Safety of the RTS,S/AS02D candidate malaria vaccine in infants living in a highly endemic area of Mozambique: a double blind randomised controlled phase I/IIb trial.
Mark E Polhemus; Alan J Magill; James F Cummings; Kent Kester; Christian F Ockenhouse; David Lanar; Sheetij Dutta; Arnoldo Barbosa; Lorraine Soisson; Carter L Diggs; Sally A Robinson; J David Haynes; V Ann Stewart; Lisa A Ware; Clara Brando; Urszula Krzych; Robert A Bowden; Joe D Cohen; Marie-Claude Dubois; Opokua Ofori-Anyinam; Els De-Kock; W Ripley Ballou; Donald Heppner
Phase I dose escalation safety and immunogenicity trial of Plasmodium falciparum apical membrane protein (AMA-1) FMP2.1, adjuvanted with AS02A, in malaria-naïve adults at the Walter Reed Army Institute of Research.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Arnoldo Barbosa (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2011: Tamara K Berthoud; Ruth Aguilar; Pedro L Alonso; Arnoldo Barbosa; Caterina Guinovart; Maria Nelia Manaca; Laura Puyol; Diana Quelhas; Carlota Dobaño
Comparison of commercial kits to measure cytokine responses to Plasmodium falciparum by multiplex microsphere suspension array technology.
Malaria journal 2011;10():115.
2007: John J Aponte; Pedro Aide; Montse Renom; Inacio Mandomando; Quique Bassat; Jahit Sacarlal; M Nelia Manaca; Sarah Lafuente; Arnoldo Barbosa; Amanda Leach; Marc Lievens; Johan Vekemans; Betuel Sigauque; Marie-Claude Dubois; Marie-Ange Demoitié; Marla Sillman; Barbara Savarese; John G McNeil; Eusebio Macete; W Ripley Ballou; Joe Cohen; Pedro L Alonso
Safety of the RTS,S/AS02D candidate malaria vaccine in infants living in a highly endemic area of Mozambique: a double blind randomised controlled phase I/IIb trial.
Lancet 2007;370(9598):1543-51.
2007: Mark E Polhemus; Alan J Magill; James F Cummings; Kent Kester; Christian F Ockenhouse; David Lanar; Sheetij Dutta; Arnoldo Barbosa; Lorraine Soisson; Carter L Diggs; Sally A Robinson; J David Haynes; V Ann Stewart; Lisa A Ware; Clara Brando; Urszula Krzych; Robert A Bowden; Joe D Cohen; Marie-Claude Dubois; Opokua Ofori-Anyinam; Els De-Kock; W Ripley Ballou; Donald Heppner
Phase I dose escalation safety and immunogenicity trial of Plasmodium falciparum apical membrane protein (AMA-1) FMP2.1, adjuvanted with AS02A, in malaria-naïve adults at the Walter Reed Army Institute of Research.
Vaccine 2007;25(21):4203-12.
2007: Clara Brando; Lisa A Ware; Helen Freyberger; April Kathcart; Arnoldo Barbosa; Sylvie Cayphas; Marie-Ange Demoitie; Pascal Mettens; Donald Heppner; David Lanar
Murine immune responses to liver-stage antigen 1 protein FMP011, a malaria vaccine candidate, delivered with adjuvant AS01B or AS02A.
Infection and immunity 2007;75(2):838-45.
2005: Sheetij Dutta; J David Haynes; Arnoldo Barbosa; Lisa A Ware; Jeffrey D Snavely; J Kathleen Moch; Alan Thomas; David Lanar
Mode of action of invasion-inhibitory antibodies directed against apical membrane antigen 1 of Plasmodium falciparum.
Infection and immunity 2005;73(4):2116-22.
2005: Collette J Hillier; Lisa A Ware; Arnoldo Barbosa; Evelina Angov; Jeffrey A Lyon; Donald Heppner; David Lanar
Process development and analysis of liver-stage antigen 1, a preerythrocyte-stage protein-based vaccine for Plasmodium falciparum.
Infection and immunity 2005;73(4):2109-15.
2004: P V Lalitha; Lisa A Ware; Arnoldo Barbosa; Sheetij Dutta; J Kathleen Moch; J David Haynes; Bader B Fileta; Charles E White; David Lanar
Production of the subdomains of the Plasmodium falciparum apical membrane antigen 1 ectodomain and analysis of the immune response.
Infection and immunity 2004;72(8):4464-70.
2004: Eunita A Ohas; John H Adams; John N Waitumbi; Alloys S S Orago; Arnoldo Barbosa; David Lanar; Jose Stoute
Measurement of antibody levels against region II of the erythrocyte-binding antigen 175 of Plasmodium falciparum in an area of malaria holoendemicity in western Kenya.
Infection and immunity 2004;72(2):735-41.
2003: Sheetij Dutta; J David Haynes; J Kathleen Moch; Arnoldo Barbosa; David Lanar
Invasion-inhibitory antibodies inhibit proteolytic processing of apical membrane antigen 1 of Plasmodium falciparum merozoites.
Proceedings of the National Academy of Sciences of the United States of America 2003;100(21):12295-300.
2003: John G Ayisi; OraLee Branch; A Rafi-Janajreh; Anna M van Eijk; Feiko O ter Kuile; Daniel H Rosen; Piet A Kager; David Lanar; Arnoldo Barbosa; David C Kaslow; Bernard L Nahlen; Altaf A Lal
Does infection with Human Immunodeficiency Virus affect the antibody responses to Plasmodium falciparum antigenic determinants in asymptomatic pregnant women?
The Journal of infection 2003;46(3):164-72.
2002: Sheetij Dutta; P V Lalitha; Lisa A Ware; Arnoldo Barbosa; J Kathleen Moch; Meredith A Vassell; Bader B Fileta; Svetlana Kitov; Nelly Kolodny; Donald Heppner; J David Haynes; David Lanar
Purification, characterization, and immunogenicity of the refolded ectodomain of the Plasmodium falciparum apical membrane antigen 1 expressed in Escherichia coli.
Infection and immunity 2002;70(6):3101-10.
2002: Oscar Kashala; Roberto Amador; Maria V Valero; Alberto Moreno; Arnoldo Barbosa; Beatrice Nickel; Claudia A Daubenberger; Fanny Guzman; Gerd Pluschke; Manuel E Patarroyo
Safety, tolerability and immunogenicity of new formulations of the Plasmodium falciparum malaria peptide vaccine SPf66 combined with the immunological adjuvant QS-21.
Vaccine 2002;20(17-18):2263-77.
2001: Sheetij Dutta; Lisa A Ware; Arnoldo Barbosa; Christian F Ockenhouse; David Lanar
Purification, characterization, and immunogenicity of a disulfide cross-linked Plasmodium vivax vaccine candidate antigen, merozoite surface protein 1, expressed in Escherichia coli.
Infection and immunity 2001;69(9):5464-70.
2001: Christian F Ockenhouse; Arnoldo Barbosa; D P Blackall; CI Murphy; Oscar Kashala; Sheetij Dutta; David Lanar; JR Daugherty
Sialic acid-dependent binding of baculovirus-expressed recombinant antigens from Plasmodium falciparum EBA-175 to Glycophorin A.
Molecular and biochemical parasitology 2001;113(1):9-21.
2000: Daniel M N Okenu; Eleanor M Riley; Quentin Bickle; P U Agomo; Arnoldo Barbosa; JR Daugherty; David Lanar; David J Conway
Analysis of human antibodies to erythrocyte binding antigen 175 of Plasmodium falciparum.
Infection and immunity 2000;68(10):5559-66.
1997: JR Daugherty; CI Murphy; LA Doros-Richert; Arnoldo Barbosa; L O Kashala; W Ripley Ballou; N J Snellings; Christian F Ockenhouse; David Lanar
Baculovirus-mediated expression of Plasmodium falciparum erythrocyte binding antigen 175 polypeptides and their recognition by human antibodies.
Infection and immunity 1997;65(9):3631-7.